Michael S. Weiss - 12 Mar 2023 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO and President, Director
Signature
/s/ Michael S. Weiss
Issuer symbol
TGTX
Transactions as of
12 Mar 2023
Net transactions value
$0
Form type
4
Filing time
14 Mar 2023, 17:00:32 UTC
Previous filing
14 Feb 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX COMMON STOCK Award $0 +985,000 +9% $0.000000 11,973,021 12 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
F2 Includes shares of restricted Common Stock, which vest over various time periods.